These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3545728)

  • 1. The effect of continuous subcutaneous insulin infusion on insulin binding to erythrocytes in diabetes mellitus.
    Ng FM; Babacan E; Cohen M; Zimmet PZ
    Diabetes Res Clin Pract; 1987; 3(1):31-7. PubMed ID: 3545728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-binding to erythrocytes in type I diabetes mellitus: effects of continuous subcutaneous infusion of insulin.
    Behme MT; Dupre J
    Clin Invest Med; 1984; 7(2):109-14. PubMed ID: 6380857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous subcutaneous insulin infusion versus multiple injections on insulin receptors in insulin-dependent diabetics.
    Lecavalier L; Havrankova J; Hamet P; Chiasson JL
    Diabetes Care; 1987; 10(3):300-5. PubMed ID: 3297578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions].
    Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H
    Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy.
    Schiffrin A; Parikh S; Marliss EB; Desrosiers MM
    Diabetes Care; 1984; 7(3):255-60. PubMed ID: 6376018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment.
    Arias P; Kerner W; de la Fuente A; Pfeiffer EF
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):250-5. PubMed ID: 6388208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.
    Simonson DC; Tamborlane WV; Sherwin RS; Smith JD; DeFronzo RA
    Diabetes; 1985 Aug; 34 Suppl 3():80-6. PubMed ID: 3894130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein subfractions during continuous insulin infusion therapy.
    Helve E
    Atherosclerosis; 1987 Apr; 64(2-3):173-80. PubMed ID: 3300667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.